You are here
- Home
- Drug Products
- All Drug Products
A Phase I Open-Label Study to Assess the Safety and Tolerability of AZD2281(KU-0059436) in Combination with carboplatin (phase I), or in combination with a carboplatin/paclitaxel doublet (phase IIa), or in combination with paclitaxel (phase IIb) in the Treatment of Patients with Advanced Solid Tumours.
- Disease
- solid tumour
- Drug Name
- Olaparib
- Generic Name
- Olaparib (AZD2281)
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jun 29, 2007
- Study Name
- KU36-96
- Study Id
- D0810C00004
- ClinicalTrials.gov ID
- NCT00516724
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
